ATE54414T1 - Antivirale mischung. - Google Patents

Antivirale mischung.

Info

Publication number
ATE54414T1
ATE54414T1 AT87300781T AT87300781T ATE54414T1 AT E54414 T1 ATE54414 T1 AT E54414T1 AT 87300781 T AT87300781 T AT 87300781T AT 87300781 T AT87300781 T AT 87300781T AT E54414 T1 ATE54414 T1 AT E54414T1
Authority
AT
Austria
Prior art keywords
antiviral
blend
combinations
nucleoside
inhibitors
Prior art date
Application number
AT87300781T
Other languages
English (en)
Inventor
Thomas Paul Zimmerman
Gerald Wolberg
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE54414T1 publication Critical patent/ATE54414T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT87300781T 1986-01-30 1987-01-29 Antivirale mischung. ATE54414T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868602346A GB8602346D0 (en) 1986-01-30 1986-01-30 Antiviral combinations
EP87300781A EP0235931B1 (de) 1986-01-30 1987-01-29 Antivirale Mischung

Publications (1)

Publication Number Publication Date
ATE54414T1 true ATE54414T1 (de) 1990-07-15

Family

ID=10592262

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87300781T ATE54414T1 (de) 1986-01-30 1987-01-29 Antivirale mischung.

Country Status (20)

Country Link
US (1) US4897394A (de)
EP (1) EP0235931B1 (de)
JP (1) JPS62195337A (de)
KR (1) KR870006900A (de)
AT (1) ATE54414T1 (de)
AU (1) AU590817B2 (de)
CA (1) CA1283361C (de)
DD (1) DD261095A5 (de)
DE (1) DE3763597D1 (de)
DK (1) DK46787A (de)
ES (1) ES2031883T3 (de)
FI (1) FI870377L (de)
GB (1) GB8602346D0 (de)
GR (1) GR3000638T3 (de)
HU (1) HU198394B (de)
IL (1) IL81422A0 (de)
MC (1) MC1791A1 (de)
PL (1) PL263871A1 (de)
PT (1) PT84219B (de)
ZA (1) ZA87667B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
EP0684822B1 (de) * 1993-02-19 2002-05-08 Southern Research Institute Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
WO1994026273A1 (en) * 1993-05-12 1994-11-24 Hostetler Karl Y Acyclovir derivatives for topical use
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
HRP20040421B1 (hr) * 2001-10-16 2013-05-31 Avanir Pharmaceuticals INHIBICIJA VIRUSA n-DOKOZANOLOM
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) * 2015-09-07 2015-11-25 夏云强 一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0108285B1 (de) * 1982-10-14 1988-04-20 The Wellcome Foundation Limited Antivirale Purinderivate
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
ES8801303A1 (es) * 1985-05-15 1987-12-16 Wellcome Found Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
HU198394B (en) 1989-10-30
KR870006900A (ko) 1987-08-13
PT84219A (en) 1987-02-01
CA1283361C (en) 1991-04-23
FI870377A7 (fi) 1987-07-31
US4897394A (en) 1990-01-30
GR3000638T3 (en) 1991-09-27
ZA87667B (en) 1988-09-28
PT84219B (pt) 1989-07-31
AU6813587A (en) 1987-08-06
ES2031883T3 (es) 1993-01-01
EP0235931B1 (de) 1990-07-11
EP0235931A1 (de) 1987-09-09
DK46787D0 (da) 1987-01-29
IL81422A0 (en) 1987-08-31
JPS62195337A (ja) 1987-08-28
DE3763597D1 (de) 1990-08-16
HUT42941A (en) 1987-09-28
DK46787A (da) 1987-07-31
DD261095A5 (de) 1988-10-19
MC1791A1 (fr) 1987-10-22
FI870377L (fi) 1987-07-31
GB8602346D0 (en) 1986-03-05
FI870377A0 (fi) 1987-01-29
AU590817B2 (en) 1989-11-16
PL263871A1 (en) 1988-05-12

Similar Documents

Publication Publication Date Title
ATE54414T1 (de) Antivirale mischung.
EP0135713A3 (de) Antivirale Zusammensetzungen
Markland et al. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
TR200102313T2 (tr) Antiviral maddeler olarak (1R, SíS)-4-(6-amino-9H-purin-9-il)-2-siklopenten-1-metanoln mono-, di ve tri-fosfat esterleri ve fosforamidatlarì
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
SE8405133L (sv) Anti-viralt medel
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
DK0630368T3 (da) Antivirale nukleosidanaloge
NO20014347D0 (no) Synergistisk inhibering av viral replikasjon ved langkjedede hydrokarboner og nukleosidanaloger
ATE281179T1 (de) Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
IE882593L (en) Aristeromycin/adenosine derivatives
ATE411806T1 (de) DIE VERWENDUNG VON PYRIMIDINNUKLEOSIDEN UND/ODER PRODRUGS DAVON ZUR BEKÄMPFUNG VON NEBENWIRKUNGEN DER ßHAARTß (HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY) UND ANDEREN ANTIVIRALEN THERAPIEN
ES548529A0 (es) Procedimiento de modificacion de celulas eucariotas.
ATE334137T1 (de) Ringerweiterte nukleoside und nukleotide
DE69813203D1 (de) Verbesserte Primer zur AFLP Amplifizierung
ATE72122T1 (de) Antivirale mischungen.
IT1177147B (it) Composizione farmaceutica per combattere infezioni virali, e procedimento di uso per le infezioni virali
FR2621816B1 (fr) Application antivirale des ologonucleotides
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물
GB563601A (en) Improvements in and relating to the tipping of saw teeth with hard metal inserts
张献珍 STABILITY IN THE LARGE OF A CLASS OF THIRD-ORDER NONLINEAR ORDINARY DIFFERENTIAL EQUATIONS
AR023390A1 (es) Terapia para la leucemia mielocitica cronica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee